Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Dilution |
1:1000-1:10000 |
Not tested in other applications.
Positive Control
SARS-CoV-2 RdRP (nsp12)-transfected 293T
Product Note
This antibody was raised against N-terminal domain of nsp12 protein, and it does not react with RdRp enzyme domain.
Form
Liquid
Buffer
1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.
Storage
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Concentration
1 mg/ml (Please refer to the vial label for the specific concentration.)
Antigen Species
SARS Coronavirus 2
Immunogen
Recombinant protein encompassing a sequence within the N-terminus region of SARS-CoV-2 (COVID-19) RdRp (nsp12) (Strain:Wuhan-Hu-1). The exact sequence is proprietary.
Purification
Affinity purified by Protein A.
Conjugation
Unconjugated
RRID
AB_2887497
Note
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Synonyms
2019-nCoV RdRp , SARS-CoV-2 RdRp , COVID-19 RdRp , 2019-nCoV RNA-directed RNA polymerase , SARS-CoV-2 RNA-directed RNA polymerase , COVID-19 RNA-directed RNA polymerase , 2019-nCoV nsp12 , SARS-CoV-2 nsp12 , COVID-19 nsp12
Research Area